Invention Grant
- Patent Title: Influenza A virus specific antibodies
-
Application No.: US14362210Application Date: 2012-12-03
-
Publication No.: US09718874B2Publication Date: 2017-08-01
- Inventor: Hergen Spits , Tim Beaumont , Mark Jeroen Kwakkenbos , Arjen Quirinus Bakker
- Applicant: Hergen Spits , Tim Beaumont , Mark Jeroen Kwakkenbos , Arjen Quirinus Bakker
- Applicant Address: NL Amsterdam Zuidoost
- Assignee: AIMM THERAPEUTICS B.V.
- Current Assignee: AIMM THERAPEUTICS B.V.
- Current Assignee Address: NL Amsterdam Zuidoost
- Agency: Saul Ewing LLP
- Agent Gianna Julian-Arnold
- Priority: EP11191783 20111202
- International Application: PCT/NL2012/050851 WO 20121203
- International Announcement: WO2013/081463 WO 20130606
- Main IPC: C07K16/10
- IPC: C07K16/10 ; G01N33/569 ; A61K39/00
Abstract:
The invention relates to isolated, synthetic or recombinant antibodies and functional parts thereof specific for multiple influenza A virus subtypes. The invention further relates to the use of such antibodies for diagnosis of an influenza A virus infection and as a medicament and/or prophylactic agent for at least in part treating or alleviating symptoms of an influenza A virus infection.
Public/Granted literature
- US20150010566A1 INFLUENZA A VIRUS SPECIFIC ANTIBODIES Public/Granted day:2015-01-08
Information query
